UnitedHealth Group faces lawsuits and federal probes over AI-driven claims denials in Medicare Advantage, highlighting regulatory risks and the need for ethical plan advisory.

The DOJ is investigating UnitedHealth Group's Medicare billing practices, focusing on diagnostic coding and in-home evaluations that may have led to inflated government payments. This probe highlights compliance and regulatory risks in Medicare Advantage programs.

HCA Healthcare's Q2 2024 earnings demonstrate strategic growth fueled by digital transformation, aging demographics, and expansion into non-acute care. Strong financial metrics and operational discipline highlight market leadership.

AultCare will stop offering individual and small group ACA plans after 2025 due to uncertainty over premium tax credits, continuing Medicare Advantage and group coverage.

CMS introduces WISeR model using AI to expedite Medicare prior authorizations while insurers enhance processes to cut waste and improve care approval speeds.

The DOJ and HHS have reestablished the False Claims Act Working Group to heighten enforcement of healthcare fraud, focusing on Medicare, Medicaid, pricing, and EHR compliance risks.

Humana's legal loss against CMS over Medicare Advantage star ratings underscores structural regulatory risks reshaping insurer margins and strategies in the U.S. Medicare Advantage market.

Humana's lawsuit challenging its Medicare Advantage star ratings was dismissed due to incomplete administrative appeals. The insurer faces a major downgrade impacting 2026 earnings and plans further legal action.

Elevance Health lowers 2024 earnings guidance due to rising medical utilization, Medicaid eligibility checks resuming, and regulatory challenges impacting Medicaid and ACA programs.

Elevance Health lowers its 2025 profit outlook due to higher ACA and Medicaid costs driven by sicker patients and increased care utilization, reflecting an industry-wide trend. Analysts anticipate persistent insurer losses before improvement in 2026.